- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05396248
Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
March 7, 2024 updated by: Nancy Chiaravalloti, Kessler Foundation
Use of a Memory Technique to Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
The current study is a double-blind, placebo-control randomized clinical trial examining the efficacy of memory retraining in individuals with Mild Cognitive Impairment (MCI).
Impairment in higher level cognitive processing, such as new learning and memory, is one of the most common deficits in individuals with MCI and such deficits have been shown to exert significant negative impact on multiple aspects of everyday life, including occupational and social functioning.
Despite these findings, few studies have attempted to treat these cognitive deficits in order to improve the everyday functioning of individuals with MCI.
Through a small randomized clinical trial, the investigators found that individuals with MCI with documented cognitive impairment show a significant improvement in their memory performance following a treatment protocol designed to facilitate learning.
The current proposal will replicate this finding and further evaluate (a) the impact of the treatment on everyday functioning, (b) the long term efficacy of the treatment and (c) the utility of booster sessions in facilitating long-term treatment effects.
We will randomly assign older individuals who meet criteria for a diagnosis of amnestic MCI to a memory retraining group or a placebo control group.
Both groups will undergo baseline, immediate and long-term follow-up assessment consisting of: (1) a traditional neuropsychological battery, (2) an assessment of global functioning examining the impact of the treatment on daily activities, and (3) functional neuroimaging.
This design will allow the investigators to evaluate the efficacy of this particular memory retraining technique in an aMCI population through the assessment of cognitive function via a standard evaluation.
In addition, the investigators will be able to draw conclusions regarding the impact of this particular memory remediation program on everyday life from questionnaires completed by the participant and a significant other.
Optional enrollment in pre- post neuroimaging will also allow the investigators to look at changes in the brain.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
120
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nancy Moore
- Phone Number: 1973-324-8450
- Email: nbmoore@kesslerfoundation.org
Study Contact Backup
- Name: Nancy Chiaravalloti
- Phone Number: 973-324-8440
- Email: nchiaravalloti@kesslerfoundation.org
Study Locations
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48105
- Recruiting
- University of Michigan
-
Contact:
- Eileen Robinson
- Phone Number: 734-763-1356
- Email: robinsoe@med.umich.edu
-
-
New Jersey
-
West Orange, New Jersey, United States, 07052
- Recruiting
- Kessler Foundation Research Center
-
Contact:
- Nancy B Moore, MA
- Phone Number: 973-324-8450
- Email: nbmoore@kesslerfoundation.org
-
Principal Investigator:
- Nancy D Chiaravalloti, PhD
-
Contact:
- Nancy D Chiaravalloti, PhD
- Phone Number: 973-324-8440
- Email: nchiaravalloti@kesslerfoundation.org
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 60 or older.
- read and speak English fluently.
- Research based diagnosis of Amnestic Mild Cognitive Impairment
Exclusion Criteria:
- prior stroke or neurological injury/disease (i.e. traumatic brain injury, Multiple Sclerosis, or Stroke).
- history of significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis).
- significant alcohol or drug abuse history (inpatient treatment).
- Benzodiazepines and steroid use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental Group
The experimental group will receive memory retraining exercises administered on a laptop computer twice a week for five weeks (10 training sessions).
|
Memory retraining exercises will be administered on a laptop computer twice a week for five weeks (10 training sessions).
|
Placebo Comparator: Placebo Control Group
The placebo control group will receive placebo memory exercises administered on a laptop computer twice a week for five weeks (10 placebo control sessions).
|
Placebo control memory exercises will be administered on a laptop computer twice a week for five weeks (10 training sessions).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Verbal list learning
Time Frame: four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Change in total score from Open-Trial Selective Reminding Test (OT-SRT)
|
four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Participation in everyday life
Time Frame: four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Change in total score from Participation Assessment with Recombined Tools
|
four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Self-reported depression
Time Frame: four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Change in total score on the Geriatric Depression Scale
|
four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Self-reported anxiety
Time Frame: four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Change in total score on the Geriatric Anxiety Scale
|
four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Self-reported quality of life
Time Frame: four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Change in total score on the Quality of Life in Alzheimer's Disease
|
four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Self-reported quality of well-being
Time Frame: four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Change in total score on the Quality of Well-Being Scale - Self-Administered
|
four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Functional neuroimaging
Time Frame: two points in time: pre-treatment and immediately following treatment
|
Change in total scores from memory task during fMRI scan
|
two points in time: pre-treatment and immediately following treatment
|
Story memory
Time Frame: four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Change in total score from Prose Memory Test
|
four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Functional memory
Time Frame: four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Change in total score from Object Location Task
|
four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Functional memory
Time Frame: four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Change in total score from the modified Everyday Memory Scenarios (EMS)
|
four points in time: pre-treatment, immediately following treatment, and 6- and 18- months after treatment is completed
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nancy Chiaravalloti, Kessler Foundation
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 28, 2023
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Study Registration Dates
First Submitted
May 18, 2022
First Submitted That Met QC Criteria
May 27, 2022
First Posted (Actual)
May 31, 2022
Study Record Updates
Last Update Posted (Actual)
March 12, 2024
Last Update Submitted That Met QC Criteria
March 7, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R-1183-22
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
University of California, San FranciscoNational Institute on Aging (NIA)Active, not recruitingMild Cognitive Impairment | Cognitive Decline | Cognitive Deterioration | Cognitive Impairment, Mild | Cognitive Deficits, MildUnited States
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.RecruitingMild Cognitive Impairment (MCI)Taiwan
-
Thomas Jefferson UniversityJohns Hopkins University; University of Pennsylvania; National Institute on Aging... and other collaboratorsCompletedMild Cognitive Impairment (MCI)United States
-
Palo Alto Veterans Institute for ResearchU.S. Army Medical Research and Development CommandCompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Assaf-Harofeh Medical CenterNeurim Pharmaceuticals Ltd.UnknownMild Cognitive Impairment (MCI)Israel
-
Xuanwu Hospital, BeijingWuhan University; Beijing Friendship Hospital; First Affiliated Hospital Xi'an... and other collaboratorsRecruitingAmnestic Mild Cognitive ImpairmentChina
-
Immunotec Inc.RecruitingMild Cognitive Impairment (MCI)Canada
-
Jennifer BramenNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAmnestic Mild Cognitive ImpairmentUnited States
-
Meir Medical CenterTerminatedMild Cognitive Impairment (MCI)Israel
Clinical Trials on Memory Retraining Exercises
-
Kessler FoundationCompletedAging | Mild Cognitive ImpairmentUnited States
-
Kessler FoundationInternational Progressive MS AllianceCompletedMemory Impairment | Cognition - Other | Multiple Sclerosis, ProgressiveUnited States
-
Kessler FoundationU.S. Department of EducationCompleted
-
Kessler FoundationEunice Kennedy Shriver National Institute of Child Health and Human Development...Completed
-
Kessler FoundationCompleted
-
Naestved HospitalRecruiting
-
Spaulding Rehabilitation HospitalCompleted
-
University of North Carolina, Chapel HillNational Institute of Dental and Craniofacial Research (NIDCR)CompletedMandibular AdvancementUnited States
-
Eytan A. DavidActive, not recruitingDizziness | Equilibrium; Disorder, Labyrinth | Inner Ear Injury | Inner Ear DiseaseCanada
-
University of California, San FranciscoSan Francisco VA Health Care SystemCompletedAlcohol Use Disorder | Mild Traumatic Brain InjuryUnited States